SCHEMBL8992581

SCHEMBL8992581

Cc1cc(CP(=O)(O)O)cc(-c2ccc3ccccc3c2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGK1 P00558 1/20 0.56
▸ PGK2 P07205 1/20 0.56
▸ AKR1C4 P17516 1/20 0.42
▸ AKR1C3 P42330 1/20 0.42
▸ AKR1C2 P52895 1/20 0.42
▸ AKR1C1 Q04828 1/20 0.42
▸ ESR1 P03372 1/20 0.40
▸ ESR2 Q92731 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ ALOX5 P09917 1/20 0.39
▸ PTPN1 P18031 1/20 0.39
▸ HSD17B1 P14061 1/20 0.38
▸ HSD17B2 P37059 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8925129 0.81 UTRN (0.39) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL8992172 0.78 PGK1 (0.53) PGK1PGK2HSD17B10
SCHEMBL8922756 0.77 CYP2A6 (0.42) AKR1C4AKR1C3AKR1C2AKR1C1ESR1
SCHEMBL839035 0.76 CYP2A6 (0.56) ESR1ESR2ALDH1A1CYP1A2CYP3A4
SCHEMBL8923309 0.76 MEN1 (0.65) HSD17B10
SCHEMBL8923310 0.76 MEN1 (0.65) HSD17B10
SCHEMBL29616518 0.74 PGK1 (0.50) PGK1PGK2CYP1A2PTPN1
SCHEMBL915502 0.74 PGK1 (0.50) PGK1PGK2CYP1A2PTPN1
Phosphoric Acid SCHEMBL30173246 0.74 ESR1 (0.61) ESR1ESR2CYP1A2ALOX5PTPN1
SCHEMBL9657892 0.74 PGK1 (0.91) PGK1PGK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5489717-A Glutamate (NMDA) receptor antagonists WARNER-LAMBERT COMPANY 1996-02-06 — — US disclosed
Send feedback